Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rafael Holdings (RFL) has shared an update.
Mark McCamish stepped down as director of Rafael Holdings, Inc. on August 5, 2024, and was promptly replaced by Mark N. Stein, MD, who brings a wealth of medical expertise to the board. As an experienced medical oncologist and seasoned clinical trial leader, Dr. Stein’s knowledge from his tenure at Columbia University and Rutgers University will provide valuable insights, particularly in the realm of immunotherapy for prostate and kidney cancer, to the company’s governance and strategic direction.
See more insights into RFL stock on TipRanks’ Stock Analysis page.